Hematology Diagnostics Market
Market Insights on Hematology Diagnostics covering sales outlook, demand forecast & up-to-date key trends
Hematology Diagnostics Market By Kit Type (Anemia & Iron Test Kits, Folic Acid Testing Kits, Sickle Cell Screening Kits, PT/INR Testing Kits, D-dimer Testing Kits, Blood Typing Kits, Leukemia Testing Kits, Sepsis Testing Kits, Antibiotic Resistance Panels, Bacterial & Fungal Panels), Modality (Point of Care, Lab-based Testing) & Region - Forecast 2022 - 2031
Hematology Diagnostics Market Outlook (2022-2031)
[228 Pages Report] Standing at a valuation of US$ 725 Mn in 2022, the global hematology diagnostics market is projected to reach US$ 1.2 Bn by the end of 2031. Demand for hematology diagnostics is anticipated to increase at a CAGR of 5.8% from 2022 to 2031.
|
Hematology Diagnostics Market Size (2022) |
US$ 725 Mn |
|
Global Market Revenue (2031) |
US$ 1.2 Bn |
|
Predicted Market Growth Rate (2022-2031) |
5.8% CAGR |
Increasing instances of blood disorders and blood cancer are expected to boost demand for diagnostic hematology over the coming years.
Let us know your requirement to get
100% FREE customization
How The Market Progressed Till June 2022?
|
Particulars |
Details |
|
H1, 2021 |
6.19% |
|
H1, 2022 Projected |
6.24% |
|
H1, 2022 Outlook |
6.14% |
|
BPS Change - H1, 2022 (O) – H1, 2022 (P) |
(-) 10 ↓ |
|
BPS Change – H1, 2022 (O) – H1, 2021 |
(-) 05 ↓ |
H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 10 BPS. However, In H1-2022, the market growth rate of hematology diagnostics is expected to fall by only 05 basis point share (BPS), as per FMI analysis.
The market for hematology diagnostics is subject to changes as per the product adoption rates and device regulations, in accordance to the macro and industrial dynamics. The key developments in the market include complete lab automation for hematology diagnostics. With the 4th wave of technology and automation around the globe, the market has been positively influenced by total laboratory automation strategies.
The market observes a decline in the BPs values due to the high costs associated with the diagnostic products and kits, as well as the poor availability of resources for point of care hematology testing in lower economic areas. Conversely, the market is set to gain traction with the increase in the adoption of next-generation hematology diagnostics such as non-invasive hematology and handheld hematology devices.
Demand Analysis of Hematology Diagnostics (2016 to 2021) Vs Projected Market Outlook (2022 to 2031)
Focus on diagnostics of multiple health conditions has bolstered over the past years and this trend is anticipated to be prominent over the forecast period as well. The market for hematology diagnostics rose at a CAGR of 4.2% CAGR from 2016 to 2021.
Rise in hematological testing, rising number of blood transfusions, growing prevalence of genetic diseases, rising geriatric population, rapid technological advancements, increasing adoption of automated hematology analyzers, and increasing instances of blood cancer are expected to majorly govern demand for hematology diagnostics through 2031.
Automation is also anticipated to be a major trend in the hematology diagnostics market owing to rising technological proliferation in the healthcare industry. The rising adoption of automated hematology analyzers is also predicted to see a hike as diagnostic labs and hospitals see an increase in healthcare automation.
Hematology diagnostic providers are anticipated to focus on developing advanced automated solutions owing to the increase in demand and adoption in the global market landscape.
High costs of hematology diagnostics and lack of awareness about these diagnostics are anticipated to hinder hematology diagnostics market growth. The market for hematology diagnostics is anticipated to progress at a CAGR of 5.8% over the forecast period.
Which Market Factors are Driving Demand for Hematology Diagnostics?
“Rising Prevalence of Blood Disorders to Favor Diagnostic Hematology Demand”
The world has seen a substantial rise in instances of blood disorders and this subsequently increased the demand for hematology diagnostics. Blood cancer cases across the world have seen a sharp spike in recent years and this is majorly influencing hematology diagnostics market potential.
“Advancements in Blood Testing Diagnostics to Boost Market Potential”
As the prevalence of blood disorders increases so does the demand for better diagnostic solutions and this promotes hematology diagnostic providers to invest in the research and development of such solutions. Rising research and development activity is anticipated to result in diagnostic solutions with better efficacy and subsequently boost demand for hematology diagnostics through 2031.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat Could Hinder Hematology Diagnostics Market Growth?
“High Costs of Diagnostics Could Restrain Demand Growth”
Novel diagnostics procedures are costly and are on the expensive side of the spectrum which makes it difficult for people with low income to attain. High costs of hematology diagnostic procedures are a major restraining factor for the global hematology diagnostics market.
Other factors such as lack of awareness and coverage exclusion from healthcare insurance are also anticipated to negatively impact the hematology diagnostics market.
Which Regions Should Hematology Diagnostic Providers Keep a Close Eye On?
Hematology diagnostics market analysis for regions such as North America, Latin America, Europe, East Asia, South Asia & Pacific, and the Middle East & Africa (MEA) has been profiled in this study.
The North America hematology diagnostics market is anticipated to hold a dominant outlook through 2031 and emerge as a highly lucrative region for hematology diagnostics providers. The rising prevalence of blood cancer and the presence of key hematology diagnostics companies are expected to be major factors propelling growth in this region.
The market for hematology diagnostics in Europe is predicted to account for a significant market share over the forecast period. Growth in this region can be attributed to rising hematology research and supportive government initiatives to boost awareness for hematology diagnostics.
East Asia and South Asia are expected to provide a lucrative setting for hematology diagnostics market growth over the forecast period. The increasing prevalence of blood disorders, rising focus on healthcare, increasing healthcare spending, and rising instances of genetic blood disorders are expected to be major drivers for the hematology diagnostics market in East Asia and South Asia.
Demand is predicted to be majorly spearheaded by emerging economies such as India and China where medical tourism is flourishing.
The hematology diagnostics market in the MEA region holds a low market share but is anticipated to see substantial growth by the end of the forecast period. Rising investments in healthcare infrastructure and supportive government initiatives are anticipated to promote hematology diagnostics market potential in this region.
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Country-wise Analysis
How is the Hematology Diagnostics Market Expected to Perform in the U.S.?
“Rising Incidence of Blood Cancer to Boost Hematology Diagnostics Demand”
The U.S. has seen a spike in the incidence of blood cancer in recent years and is expected to see an increase over the forecast period as well. The U.S. market for hematology diagnostics is expected to provide highly lucrative opportunities due to high technological proliferation, the presence of developed healthcare infrastructure, and high research and development activity.
Will India Be a Lucrative Market for Hematology Diagnostic Companies?
“Increasing Focus on Healthcare to Positively Impact Hematology Diagnostics Market Potential”
Focus on healthcare has bolstered in recent years in India and this has created many opportunities for healthcare diagnostic providers. The nation is also experiencing a surge in instances of blood disorders and incidence of blood cancer which is also a factor that promotes demand for hematology diagnostics.
Hematology diagnostic providers can focus on India and gain from the untapped potential that the market has to offer and increase their global revenue potential.
Category-wise Analysis
Which Distribution Channel is Expected to Be Most Lucrative?
“Hospitals to Hold Dominant Outlook throughout Forecast Period”
Currently, the hospitals segment holds a dominant market share and is predicted to maintain this stance through 2031. However, the diagnostic laboratories segment is expected to experience rapid growth over the forecast period owing to an increasing number of diagnostic centers and increasing availability of advanced diagnostic instruments and devices.
COVID-19 Crisis Survey
In 2020, the world was plagued with coronavirus infections that led to a pandemic situation across the world. This unprecedented phenomenon took the markets by shock and had an adverse impact on the world economy.
The hematology diagnostics market also toppled amidst the lockdown restrictions that were imposed by multiple countries to contain the spread of coronavirus infections. However, demand for hematology diagnostics is expected to see a steady rise in the post-pandemic era and offer hematology diagnostic providers a chance to make a complete recovery from losses in 2020.
Competitive Landscape
Hematology diagnostic providers are investing in the research & development of novel diagnostic solutions to enhance their market presence and boost revenue generation potential.
Hematology diagnostic companies are also focusing on establishing new diagnostic centres to deploy novel diagnostic solutions.
- In October 2021, Suburban Diagnostics, a leading name in the medical diagnostics industry, announced the launch of the Centre of Excellence in Hematology. The new establishment provides research support and training of diagnostic procedures for multiple common and uncommon hematological disorders.
Hematology Diagnostics Industry Report Scope
|
Attribute |
Details |
|
Forecast Period |
2022-2031 |
|
Historical Data Available for |
2016-2021 |
|
Market Analysis |
US$ Mn for Value |
|
Key Regions Covered |
|
|
Key Countries Covered |
|
|
Key Market Segments Covered |
|
|
Key Companies Profiled |
|
|
Pricing |
Available upon Request |
Key Segments of Hematology Diagnostics Industry Survey
Hematology Diagnostics Market by Kit Type:
- Anemia and Iron Test Kits
- Folic Acid Testing Kits
- Sickle Cell Screening Kits
- PT/INR Testing Kits
- D-dimer Testing Kits
- Blood Typing Kits
- Leukemia Testing Kits
- Sepsis Testing Kits
- Antibiotic Resistance Panels
- Bacterial & Fungal Panels
Hematology Diagnostics Market by Modality:
- Point of Care Hematology Diagnostics
- Lab-based Testing Hematology Diagnostics
Hematology Diagnostics Market by Distribution Channel:
- Hematology Diagnostics for Hospitals
- Hematology Diagnostics for Diagnostic Laboratories
- Hematology Diagnostics for Cancer Research Institutes
- Hematology Diagnostics for Retail Pharmacies
- Hematology Diagnostics for Drug Stores
- Hematology Diagnostics for Online Sales Channels
Hematology Diagnostics Market by Region:
- North America Hematology Diagnostics Market
- Latin America Hematology Diagnostics Market
- Europe Hematology Diagnostics Market
- East Asia Hematology Diagnostics Market
- South Asia & Pacific Hematology Diagnostics Market
- Middle East & Africa (MEA) Hematology Diagnostics Market
Frequently Asked Questions
In 2022, the global hematology diagnostics market is valued at US$ 725 Mn.
The hospitals segment holds a dominant outlook in the global hematology diagnostics landscape.
As per these hematology diagnostics market insights, the industry is predicted to progress at a CAGR of 5.8% from 2022 to 2031.
By 2031, the hematology diagnostics market is predicted to rake in sales revenue worth US$ 1.2 Bn.
Prime market players such as Siemens Healthlineers, F. Hoffman-La Roche Ltd., HORIBA Ltd., HemoCue AB, Danaher (Beckman Coulter Inc.), Nihon Kohden Corporation, EKF Diagnostics, Ortho Clinical Diagnostics, and Drew Scientific are profiled in this hematology diagnostics market survey.
Table of Content
Section 01 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section 02 Assumptions and Research Methodology
2.1 Assumptions
2.2 Research Methodology
Section 03 Executive Summary
3.1 Global Market Size (US$ Mn) and Distribution by Geography, 2016 - 2021
3.2 Global Market Snapshot, 2016
3.3 Global Market: Opportunity Map
Section 04 Market Overview
4.1 Overview
4.2 Global Market Size (US$ Mn) Forecast, 2016 - 2021
4.3 Global Market Outlook
4.4 Global Market: Porter’s Five Forces Analysis
4.5 Hematology Analyzers Installed Base
4.6 Key Success factor for Top 3 Players
4.7 Technological Advancements
4.8 Disease Prevalence & Incidence Rate Globally with Key Countries
Section 05 Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Opportunity Analysis
5.4 Opportunities
5.5 Trends
Section 06 Market Analysis, by Product Type
6.1 Introduction
6.2 Global Market Value Share Analysis, by Product Type
6.3 Market Analysis, by Product Type
6.3.1 Hematology Instruments
6.3.1.1 Hematology Analyzers
6.3.1.1.1 Fully-automated Hematology Analyzers
6.3.1.1.2 Semi-automated Hematology Analyzers
6.3.1.2 Flow Cytometers
6.3.1.3 Others
6.3.2 Hematology Consumables
6.3.2.1 Reagents
6.3.2.2 Stains
6.3.2.3 Controls & Calibrators
6.3.2.4 Others
6.4 Market Attractiveness Analysis, by Product Type
6.5 Market Attractiveness Analysis, by Hematology Analyzers
6.6 Market Attractiveness Analysis, by Hematology Consumables
Section 07 Market Analysis, by End-user
7.1 Introduction
7.2 Global Market Value Share Analysis, by End-user
7.3 Market Analysis, by End-user
7.3.1 Diagnostic Laboratories
7.3.2 Hospitals & Clinics
7.3.3 Academic Institutes
7.3.4 Others
7.4 Market Attractiveness Analysis, by End-user
Section 08 Market Analysis, by Region
8.1 Global Market Snapshot, by Country
8.2 Global Market Value Share Analysis, by Region
8.3 Market Forecast, by Region
8.3.1 North America
8.3.2 Europe
8.3.3 Asia Pacific
8.3.4 Latin America
8.3.5 Middle East & Africa
8.4 Market Attractiveness Analysis, by Region
8.5 Market: Regional Trends
Section 09 North America Market Analysis
9.1 Key Findings
9.2 North America Market Overview
9.3 North America Market Value Share Analysis, by Product Type
9.4 North America Market Forecast, by Product Type
9.4.1 Hematology Instruments
9.4.2 Hematology Consumables
9.5 North America Market Value Share Analysis, by Hematology Instruments
9.6 North America Market Forecast, by Hematology Instruments
9.6.1 Hematology Analyzers
9.6.2 Flow Cytometers
9.6.3 Others
9.7 North America Market Value Share Analysis, by Hematology Consumables
9.8 North America Market Forecast, by Hematology Consumables
9.8.1 Reagents
9.8.2 Stains
9.8.3 Controls & Calibrators
9.8.4 Others
9.9 North America Market Value Share Analysis, by End-user
9.10 North America Market Forecast, by End-user
9.10.1 Diagnostic Laboratories
9.10.2 Hospitals & Clinics
9.10.3 Academic Institutes
9.10.4 Others
9.11 Market Analysis, by Country
9.12 Market Value Share Analysis, by Country
9.13 Market Size (US$ Mn) Forecast, by Country, 2022-2031
9.13.1 U.S.
9.13.2 Canada
9.14 Market Attractiveness Analysis
9.14.1 by Product Type
9.14.2 by Hematology Instruments
9.14.3 by Hematology Consumables
9.14.4 by End-user
9.14.5 by Country
Section 10 Europe Market Analysis
10.1 Key Findings
10.2 Europe Market Overview
10.3 Europe Market Value Share Analysis, by Product Type
10.4 Europe Market Forecast, by Product Type
10.4.1 Hematology Instruments
10.4.2 Hematology Consumables
10.5 Europe Market Value Share Analysis, by Hematology Instruments
10.6 Europe Market Forecast, by Hematology Instruments
10.6.1 Hematology Analyzers
10.6.2 Flow Cytometers
10.6.3 Others
10.7 Europe Market Value Share Analysis, by Hematology Consumables
10.8 Europe Market Forecast, by Hematology Consumables
10.8.1 Reagents
10.8.2 Stains
10.8.3 Controls & Calibrators
10.8.4 Others
10.9 Europe Market Value Share Analysis, by End-user
10.10 Europe Market Forecast, by End-user
10.10.1 Diagnostic Laboratories
10.10.2 Hospitals & Clinics
10.10.3 Academic Institutes
10.10.4 Others
10.11 Market Analysis, by Country
10.12 Market Value Share Analysis, by Country
10.13 Market Size (US$ Mn) Forecast, by Country, 2022-2031
10.13.1 Germany
10.13.2 France
10.13.3 U.K.
10.13.4 Italy
10.13.5 Spain
10.13.6 Rest of Europe
10.14 Market Attractiveness Analysis
10.14.1 by Product Type
10.14.2 by Hematology Instruments
10.14.3 by Hematology Consumables
10.14.4 by End-user
10.14.5 by Country
Section 11 Asia Pacific Market Analysis
11.1 Key Findings
11.2 Asia Pacific Market Overview
11.3 Asia Pacific Market Value Share Analysis, by Product Type
11.4 Asia Pacific Market Forecast, by Product Type
11.4.1 Hematology Instruments
11.4.2 Hematology Consumables
11.5 Asia Pacific Market Value Share Analysis, by Hematology Instruments
11.6 Asia Pacific Market Forecast, by Hematology Instruments
11.6.1 Hematology Analyzers
11.6.2 Flow Cytometers
11.6.3 Others
11.7 Asia Pacific Market Value Share Analysis, by Hematology Consumables
11.8 Asia Pacific Market Forecast, by Hematology Consumables
11.8.1 Reagents
11.8.2 Stains
11.8.3 Controls & Calibrators
11.8.4 Others
11.9 Asia Pacific Market Value Share Analysis, by End-user
11.10 Asia Pacific Market Forecast, by End-user
11.10.1 Diagnostic Laboratories
11.10.2 Hospitals & Clinics
11.10.3 Academic Institutes
11.10.4 Others
11.11 Market Analysis, by Country
11.12 Market Value Share Analysis, by Country
11.13 Market Size (US$ Mn) Forecast, by Country, 2022-2031
11.13.1 China
11.13.2 Japan
11.13.3 India
11.13.4 Australia & New Zealand
11.13.5 Rest of Asia Pacific
11.14 Market Attractiveness Analysis
11.14.1 by Product Type
11.14.2 by Hematology Instruments
11.14.3 by Hematology Consumables
11.14.4 by End-user
11.14.5 by Country
Section 12 Latin America Market Analysis
12.1 Key Findings
12.2 Latin America Market Overview
12.3 Latin America Market Value Share Analysis, by Product Type
12.4 Latin America Market Forecast, by Product Type
12.4.1 Hematology Instruments
12.4.2 Hematology Consumables
12.5 Latin America Market Value Share Analysis, by Hematology Instruments
12.6 Latin America Market Forecast, by Hematology Instruments
12.6.1 Hematology Analyzers
12.6.2 Flow Cytometers
12.6.3 Others
12.7 Latin America Market Value Share Analysis, by Hematology Consumables
12.8 Latin America Market Forecast, by Hematology Consumables
12.8.1 Reagents
12.8.2 Stains
12.8.3 Controls & Calibrators
12.8.4 Others
12.9 Latin America Market Value Share Analysis, by End-user
12.10 Latin America Market Forecast, by End-user
12.10.1 Diagnostic Laboratories
12.10.2 Hospitals & Clinics
12.10.3 Academic Institutes
12.10.4 Others
12.11 Market Analysis, by Country
12.12 Market Value Share Analysis, by Country
12.13 Market Size (US$ Mn) Forecast, by Country, 2022-2031
12.13.1 Brazil
12.13.2 Mexico
12.13.3 Rest of Latin America
12.14 Market Attractiveness Analysis
12.14.1 by Product Type
12.14.2 by Hematology Instruments
12.14.3 by Hematology Consumables
12.14.4 by End-user
12.14.5 by Country
Section 13 Middle East & Africa Market Analysis
13.1 Key Findings
13.2 Middle East & Africa Market Overview
13.3 Middle East & Africa Market Value Share Analysis, by Product Type
13.4 Middle East & Africa Market Forecast, by Product Type
13.4.1 Hematology Instruments
13.4.2 Hematology Consumables
13.5 Middle East & Africa Market Value Share Analysis, by Hematology Instruments
13.6 Middle East & Africa Market Forecast, by Hematology Instruments
13.6.1 Hematology Analyzers
13.6.2 Flow Cytometers
13.6.3 Others
13.7 Middle East & Africa Market Value Share Analysis, by Hematology Consumables
13.8 Middle East & Africa Market Forecast, by Hematology Consumables
13.8.1 Reagents
13.8.2 Stains
13.8.3 Controls & Calibrators
13.8.4 Others
13.9 Middle East & Africa Market Value Share Analysis, by End-user
13.10 Middle East & Africa Market Forecast, by End-user
13.10.1 Diagnostic Laboratories
13.10.2 Hospitals & Clinics
13.10.3 Academic Institutes
13.10.4 Others
13.11 Market Analysis, by Country
13.12 Market Value Share Analysis, by Country
13.13 Market Size (US$ Mn) Forecast, by Country, 2022-2031
13.13.1 GCC Countries
13.13.2 South Africa
13.13.3 Rest of Middle East & Africa
13.14 Market Attractiveness Analysis
13.14.1 By Product Type
13.14.2 by Hematology Instruments
13.14.3 by Hematology Consumables
13.14.4 by End-user
13.14.5 by Country
Section 14 Competition Landscape
14.1 Competition Matrix
14.2 Market Share Analysis, by Company (2016)
14.3 Company Profiles
14.3.1 Abbott Laboratories
14.3.1.1 Company Description
14.3.1.2 Financial Overview
14.3.1.3 Strategy & Recent Developments
14.3.1.4 SWOT Analysis
14.3.2 Bio-Rad Laboratories, Inc.
14.3.2.1 Company Description
14.3.2.2 Financial Overview
14.3.2.3 Strategy & Recent Developments
14.3.2.4 SWOT Analysis
14.3.3 Sysmex Corporation
14.3.3.1 Company Description
14.3.3.2 Financial Overview
14.3.3.3 Strategy & Recent Developments
14.3.3.4 SWOT Analysis
14.3.4 Mindray Medical International Limited
14.3.4.1 Company Description
14.3.4.2 Financial Overview
14.3.4.3 Strategy & Recent Developments
14.3.4.4 SWOT Analysis
14.3.5 Siemens Healthineers
14.3.5.1 Company Description
14.3.5.2 Financial Overview
14.3.5.3 Strategy & Recent Developments
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche Ltd.
14.3.6.1 Company Description
14.3.6.2 Financial Overview
14.3.6.3 Strategy & Recent Developments
14.3.6.4 SWOT Analysis
14.3.7 HORIBA, Ltd.
14.3.7.1 Company Description
14.3.7.2 Financial Overview
14.3.7.3 Strategy & Recent Developments
14.3.7.4 SWOT Analysis
14.3.8 HemoCue AB
14.3.8.1 Company Description
14.3.8.2 Financial Overview
14.3.8.3 Strategy & Recent Developments
14.3.8.4 SWOT Analysis
14.3.9 Danaher (Beckman Coulter, Inc.)
14.3.9.1 Company Description
14.3.9.2 Financial Overview
14.3.9.3 Strategy & Recent Developments
14.3.9.4 SWOT Analysis
14.3.10 Nihon Kohden Corporation
14.3.10.1 Company Description
14.3.10.2 Financial Overview
14.3.10.3 Strategy & Recent Developments
14.3.10.4 SWOT Analysis
14.3.11 EKF Diagnostics
14.3.11.1 Company Description
14.3.11.2 Financial Overview
14.3.11.3 Strategy & Recent Developments
14.3.11.4 SWOT Analysis
14.3.12 Ortho Clinical Diagnostics
14.3.12.1 Company Description
14.3.12.2 Financial Overview
14.3.12.3 Strategy & Recent Developments
14.3.12.4 SWOT Analysis
14.3.13 Drew Scientific
14.3.13.1 Company Description
14.3.13.2 Financial Overview
14.3.13.3 Strategy & Recent Developments
14.3.13.4 SWOT Analysis
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Market Analysis, by Installed Base
Table 02: Global Market Size (US$ Mn) Forecast, by Product Type, 2016–2031
Table 03: Global Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2031
Table 04: Global Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2031
Table 05: Global Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2031
Table 06: Global Market Size (US$ Mn) Forecast, by End-user, 2016–2031
Table 07: Global Market Size (US$ Mn) Forecast, by Region, 2016–2031
Table 08: North America Market Size (US$ Mn) Forecast, by Country, 2016–2031
Table 09: North America Market Size (US$ Mn) Forecast, by Product Type, 2016–2031
Table 10: North America Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2031
Table 11: North America Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2031
Table 12: North America Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2031
Table 13: North America Market Size (US$ Mn) Forecast, by End-user, 2016–2031
Table 14: Europe Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2031
Table 15: Europe Market Size (US$ Mn) Forecast, by Product Type, 2016–2031
Table 16: Europe Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2031
Table 17: Europe Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2031
Table 18: Europe Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2031
Table 19: Europe Market Size (US$ Mn) Forecast, by End-user, 2016–2031
Table 20: Asia Pacific Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2031
Table 21: Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2016–2031
Table 22: Asia Pacific Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2031
Table 23: Asia Pacific Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2031
Table 24: Asia Pacific Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2031
Table 25: Asia Pacific Market Size (US$ Mn) Forecast, by End-user, 2016–2031
Table 26: Latin America Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2031
Table 27: Latin America Market Size (US$ Mn) Forecast, by Product Type, 2016–2031
Table 28: Latin America Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2031
Table 29: Latin America Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2031
Table 30: Latin America Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2031
Table 31: Latin America Market Size (US$ Mn) Forecast, by End-user, 2016–2031
Table 32: Middle East & Africa Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2031
Table 33: Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2016–2031
Table 34: Middle East & Africa Market Size (US$ Mn) Forecast, by Hematology Instruments, 2016–2031
Table 35: Middle East & Africa Market Size (US$ Mn) Forecast, by Hematology Analyzers, 2016–2031
Table 36: Middle East & Africa Market Size (US$ Mn) Forecast, by Hematology Consumables, 2016–2031
Table 37: Middle East & Africa Market Size (US$ Mn) Forecast, by End-user, 2016–2031
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Size (US$ Mn) and Distribution, by Region, 2016-2021
Figure 02: Global Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 03: Market Value Share, by Product Type, 2016
Figure 04: Market Value Share, by Hematology Consumables, 2016
Figure 05: Market Value Share, by Hematology Instruments, 2016
Figure 06: Market Value Share, by Region, 2016
Figure 07: Expected New Cases of Leukemia, Lymphoma, or Myeloma in 2016
Figure 08: Global Market Value Share, by Product Type, 2016-2021
Figure 09: Global Market Value Share, by Hematology Instruments, 2016-2021
Figure 10: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hematology Analyzers, 2016–2026
Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Flow Cytometers, 2016–2026
Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 13: Global Market Value Share, by Hematology Consumables, 2016-2021
Figure 14: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents, 2016–2026
Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Stains, 2016–2026
Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Controls & Calibrators, 2016–2026
Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 19: Global Market Attractiveness Analysis, by Hematology Instruments, 2022-2031
Figure 18: Global Market Attractiveness Analysis, by Product Type, 2022-2031
Figure 20: Global Market Attractiveness Analysis, by Hematology Consumables, 2022-2031
Figure 21: Global Market Value Share, by End-user, 2016-2021
Figure 22: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2016–2026
Figure 23: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals & Clinics, 2016–2026
Figure 24: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Academic Institutes, 2016–2026
Figure 25: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2016–2026
Figure 26: Global Market Attractiveness Analysis, by End-user, 2022-2031
Figure 27: Global Market Value Share, by Region, 2016-2021
Figure 28: Global Market Attractiveness Analysis, by Region, 2022-2031
Figure 29: North America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 30: North America Market Value Share, by Country, 2016-2021
Figure 31: North America Market Attractiveness, by Country, 2022-2031
Figure 32: North America Market Value Share, by Product Type, 2016-2021
Figure 33: North America Market Attractiveness, by Product Type, 2022-2031
Figure 34: North America Market Value Share, by Hematology Instruments, 2016-2021
Figure 35: North America Market Attractiveness, by Hematology Instruments, 2022-2031
Figure 36: North America Market Value Share, by Hematology Consumables, 2016-2021
Figure 37: North America Market Attractiveness, by Hematology Consumables, 2022-2031
Figure 38: North America Market Value Share, by End-user, 2016-2021
Figure 39: North America Market Attractiveness, by End-user, 2022-2031
Figure 40: Europe Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 41: Europe Market Value Share, by Country/Sub-region, 2016-2021
Figure 42: Europe Market Attractiveness, by Country/Sub-region, 2022-2031
Figure 43: Europe Market Value Share, by Product Type, 2016-2021
Figure 44: Europe Market Attractiveness, by Product Type, 2022-2031
Figure 45: Europe Market Value Share, by Hematology Instruments, 2016-2021
Figure 46: Europe Market Attractiveness, by Hematology Instruments, 2022-2031
Figure 47: Europe Market Value Share, by Hematology Consumables, 2016-2021
Figure 48: Europe Market Attractiveness, by Hematology Consumables, 2022-2031
Figure 49: Europe Market Value Share, by End-user, 2016-2021
Figure 50: Europe Market Attractiveness, by End-user, 2022-2031
Figure 51: Asia Pacific Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 52: Asia Pacific Market Value Share, by Country/Sub-region, 2016-2021
Figure 53: Asia Pacific Market Attractiveness, by Country/Sub-region, 2022-2031
Figure 54: Asia Pacific Market Value Share, by Product Type, 2016-2021
Figure 55: Asia Pacific Market Attractiveness, by Product Type, 2022-2031
Figure 56: Asia Pacific Market Value Share, by Hematology Instruments, 2016-2021
Figure 57: Asia Pacific Market Attractiveness, by Hematology Instruments, 2022-2031
Figure 58: Asia Pacific Market Value Share, by Hematology Consumables, 2016-2021
Figure 59: Asia Pacific Market Attractiveness, by Hematology Consumables, 2022-2031
Figure 60: Asia Pacific Market Value Share, by End-user, 2016-2021
Figure 61: Europe Market Attractiveness, by End-user, 2022-2031
Figure 62: Latin America Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 63: Latin America Market Value Share, by Country/Sub-region, 2016-2021
Figure 64: Latin America Market Attractiveness, by Country/Sub-region, 2022-2031
Figure 65: Latin America Market Value Share, by Product Type, 2016-2021
Figure 66: Latin America Market Attractiveness, by Product Type, 2022-2031
Figure 67: Latin America Market Attractiveness, by Hematology Instruments, 2022-2031
Figure 68: Latin America Market Value Share, by Hematology Instruments, 2016-2021
Figure 69: Latin America Market Value Share, by Hematology Consumables, 2016-2021
Figure 70: Latin America Market Attractiveness, by Hematology Consumables, 2022-2031
Figure 71: Latin America Market Value Share, by End-user, 2016-2021
Figure 72: Latin America Market Attractiveness, by End-user, 2022-2031
Figure 73: Middle East & Africa Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 74: Middle East & Africa Market Value Share, by Country/Sub-region, 2016-2021
Figure 75: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2022-2031
Figure 76: Middle East & Africa Market Value Share, by Product Type, 2016-2021
Figure 77: Middle East & Africa Market Attractiveness, by Product Type, 2022-2031
Figure 78: Middle East & Africa Market Value Share, by Hematology Instruments, 2016-2021
Figure 79: Middle East & Africa Market Attractiveness, by Hematology Instruments, 2022-2031
Figure 80: Middle East & Africa Market Value Share, by Hematology Consumables, 2016-2021
Figure 81: Middle East & Africa Market Attractiveness, by Hematology Consumables, 2022-2031
Figure 82: Middle East & Africa Market Value Share, by End-user, 2016-2021
Figure 83: Middle East & Africa Market Attractiveness, by End-user, 2022-2031
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
